Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Chang, Joy ^a   De Sousa, Amina ^b   Sabatier, Jennifer ^a   Assane, Mariamo ^b   Zhang, Guoqing ^a   Bila, Dulce ^c   Vaz, Paula ^c   Alfredo, Charity ^a   Cossa, Loide ^b   Bhatt, Nilesh ^b   Koumans, Emilia H ^a   Yang, Chunfu ^a   Rivadeneira, Emilia ^a   Jani, Ilesh ^b   Houston, James C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^c Fundaco Ariel Glaser Contra O SIDA Pediátrico Ariel   (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRAL THERAPY; CHILD; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FINGER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; NONHUMAN; PATIENT MONITORING; PLASMA; VIRAL LOAD TESTING; ADOLESCENT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRIED BLOOD SPOT TESTING; DRUG EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; VIROLOGY; VIRUS LOAD;

ANTIRETROVIRUS AGENT;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRIED BLOOD SPOT TESTING; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; MOZAMBIQUE; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; VIRAL LOAD;

EID: 85024404472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0181054     Document Type: Article

References (38)

1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva, Switzerland. 2013.
2. WHO. Technical and operational considerations for implementing HIV viral load testing. July 2014 ed. Geneva, Switzerland. 2014.
3. Rollins NC, Dedicoat M, Danaviah S, Page T, Bishop K, Kleinschmidt I, et al. Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet. 2002; 360(9330):389. PMID: 12241784.
4. Mehta N, Trzmielina S, Nonyane BA, Eliot MN, Lin R, Foulkes AS, et al. Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR. PLoS One. 2009; 4(6):e5819. https://doi.org/10. 1371/journal.pone.0005819 PMID: 19503790; PubMed Central PMCID: PMCPMC2688035.
5. Chohan BH, Emery S, Wamalwa D, John-Stewart G, Majiwa M, Ng'ayo M, et al. Evaluation of a single round polymerase chain reaction assay using dried blood spots for diagnosis of HIV-1 infection in infants in an African setting. BMC Pediatr. 2011; 11:18. https://doi.org/10.1186/1471-2431-11-18 PMID: 21332984; PubMed Central PMCID: PMCPMC3050718.
6. Lilian RR, Kalk E, Bhowan K, Berrie L, Carmona S, Technau K, et al. Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age. J Clin Microbiol. 2012; 50(7):2373-7. https://doi.org/10.1128/JCM.00431-12 PMID: 22518871; PubMed Central PMCID: PMCPMC3405609.
7. Lilian RR, Kalk E, Technau KG, Sherman GG. Birth diagnosis of HIV infection in infants to reduce infant mortality and monitor for elimination of mother-to-child transmission. Pediatr Infect Dis J. 2013; 32 (10):1080-5. https://doi.org/10.1097/INF.0b013e318290622e PMID: 23574775.
8. Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr. 2005; 38 (5):615-7. PMID: 15793374.
9. Parry CM, Parkin N, Diallo K, Mwebaza S, Batamwita R, DeVos J, et al. Field study of dried blood spot specimens for HIV-1 drug resistance genotyping. J Clin Microbiol. 2014; 52(8):2868-75. https://doi.org/10.1128/JCM.00544-14 PMID: 24871219; PubMed Central PMCID: PMCPMC4136191.
10. Diallo K, Lehotzky E, Zhang J, Zhou Z, de Rivera IL, Murillo WE, et al. Evaluation of a dried blood and plasma collection device, SampleTanker((R)), for HIV type 1 drug resistance genotyping in patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses. 2014; 30(1):67-73. https://doi.org/10. 1089/aid.2013.0127 PMID: 23944768.
11. Rottinghaus EK, Beard RS, Bile E, Modukanele M, Maruping M, Mine M, et al. Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring. PLoS One. 2014; 9(10):e109060. https://doi.org/10.1371/journal. pone.0109060 PMID: 25303690; PubMed Central PMCID: PMCPMC4193826.
12. Rutstein SE, Kamwendo D, Lugali L, Thengolose I, Tegha G, Fiscus SA, et al. Measures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals. J Clin Virol. 2014; 60(4):392-8. https://doi.org/10.1016/j.jcv. 2014.05.005 PMID: 24906641; PubMed Central PMCID: PMCPMC4073118.
13. Garrido C, Zahonero N, Corral A, Arredondo M, Soriano V, de Mendoza C. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests. J Clin Microbiol. 2009; 47(4):1031-6. https://doi.org/10.1128/JCM.02099-08 PMID: 19193847; PubMed Central PMCID: PMCPMC2668340.
14. Marconi A, Balestrieri M, Comastri G, Pulvirenti FR, Gennari W, Tagliazucchi S, et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect. 2009; 15(1):93-7. https://doi.org/10.1111/j.1469-0691.2008.02116.x PMID: 19220340.
15. Leelawiwat W, Young NL, Chaowanachan T, Ou CY, Culnane M, Vanprapa N, et al. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J Virol Methods. 2009; 155(2):109-17. https://doi. org/10.1016/j.jviromet.2008.09.022 PMID: 18952125.
16. Reigadas S, Schrive MH, Aurillac-Lavignolle V, Fleury HJ. Quantitation of HIV-1 RNA in dried blood and plasma spots. J Virol Methods. 2009; 161(1):177-80. https://doi.org/10.1016/j.jviromet.2009.06.002 PMID: 19523984.
17. Brambilla D, Jennings C, Aldrovandi G, Bremer J, Comeau AM, Cassol SA, et al. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol. 2003; 41(5):1888-93. PubMed Central PMCID: PMCPMC154666. https://doi.org/10.1128/JCM.41.5.1888-1893.2003 PMID: 12734222
18. Lofgren SM, Morrissey AB, Chevallier CC, Malabeja AI, Edmonds S, Amos B, et al. Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities. AIDS. 2009; 23(18):2459-66. https://doi.org/10.1097/QAD. 0b013e328331f702 PMID: 19741481; PubMed Central PMCID: PMCPMC2890230.
19. Ouma KN, Basavaraju SV, Okonji JA, Williamson J, Thomas TK, Mills LA, et al. Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya. J Clin Microbiol. 2013; 51(4):1208-18. https://doi.org/10.1128/JCM.03048-12 PMID: 23390278; PubMed Central PMCID: PMCPMC3666812.
20. Schmitz ME, Agolory S, Junghae M, Broyles LN, Kimeu M, Ombayo J, et al. Field Evaluation of Dried Blood Spots for HIV-1 Viral Load Monitoring in Adults and Children Receiving Antiretroviral Treatment in Kenya: Implications for Scale-up in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2017; 74(4):399-406. https://doi.org/10.1097/QAI.0000000000001275 PMID: 28002185.
21. Roche Molecular Systems I. COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, version 2.0. NJ, USA2010.
22. Abbott Molecular I. Abbott RealTime HIV-1. 2016.
23. CDC. GUIDELINES FOR THE SHIPMENT OF DRIED BLOOD SPOT SPECIMENS Post on: http://www.cdc.gov/od/ohs/biosfty/driblood.htm2001 [July 26, 2016].
24. Abbott Molecular I, inventorAbbott RealTime HIV-1.2010.
25. Fleiss JL. Statistical Methods for Rates and Proportions, 2nd Edition. New York: John Wiley & Sons Ltd; 1981 1981.
26. WHO. Consolidated ARV guidelines. Geneva, Switzerland2013.
27. WHO. ADHERENCE TO LONG-TERM THERAPIES: Evidence for action. Geneva, Switzerland.2003.
28. WHO. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: recommendations towards a public health approach. 2010.
29. Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, Simoni JM, et al. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med. 2011; 8(3):e1000422. https://doi.org/10.1371/journal.pmed.1000422 PMID: 21390262; PubMed Central PMCID: PMCPMC3046986.
30. Mermin J, Ekwaru JP, Were W, Degerman R, Bunnell R, Kaharuza F, et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ. 2011; 343:d6792. https://doi.org/10.1136/bmj.d6792 PMID: 22074711; PubMed Central PMCID: PMCPMC3213241.
31. Paintsil E, Martin R, Goldenthal A, Bhandari S, Andiman W, Ghebremichael M. Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ Tcells Over Time. J AIDS Clin Res. 2016; 7(4). https://doi.org/10.4172/2155-6113.1000565 PMID: 27379199; PubMed Central PMCID: PMCPMC4929848.
32. Kanapathipillai R, McManus H, Kamarulzaman A, Lim PL, Templeton DJ, Law M, et al. The significance of HIV 'blips' in resource-limited settings: is it the same? analysis of the treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD). PloS one. 2014; 9(2): e86122. https://doi.org/10.1371/journal.pone.0086122 PMID: 24516527; PubMed Central PMCID: PMCPMC3917848.
33. Nguyen S, Ramos A, Chang J, Li B, Shanmugam V, Boeras D, et al. Monitoring the quality of HIV-1 viral load testing through a proficiency testing program using dried tube specimens in resource-limited settings. J Clin Microbiol. 2015; 53(4):1129-36. https://doi.org/10.1128/JCM.02780-14 PMID: 25609733; PubMed Central PMCID: PMCPMC4365191.
34. Amendola A, Marsella P, Bloisi M, Forbici F, Angeletti C, Capobianchi MR. Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels ( 35.van Rensburg EJ, Tait K, Watt A, Schall R.Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay.J Clin Microbiol.2011;49(1):377-9.https://doi.org/10.1128/JCM.01285-10PMID: 20980564; PubMed Central PMCID: PMCPMC3020483
35. Nkeze J, Liang D, Adkins H, Zhao RY. Comparison of HIV-1 Viral Load between Abbott m2000 and Roche COBAS TaqMan Methods. Journal of Antivirals & Antiretrovirals. 2010; 2(3):042-5.
36. WHO. Public reports of WHO prequalified IVDs.
37. Pirillo MF, Recordon-Pinson P, Andreotti M, Mancini MG, Amici R, Giuliano M. Quantification of HIVRNA from dried blood spots using the Siemens VERSANT(R) HIV-1 RNA (kPCR) assay. J Antimicrob Chemother. 2011; 66(12):2823-6. https://doi.org/10.1093/jac/dkr383 PMID: 21930572.
38. Taieb F, Tram TH, Ho HT, Pham VA, Nguyen L, Pham BH, et al. Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338). Open Forum Infect Dis. 2016; 3(3):7. https://doi.org/10.1093/ofid/ofw142 PMID: 27704001; PubMed Central PMCID: PMCPMC5047401.